Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Embolization for Hypervascular Head and Neck Tumors
NCT05490381Phase 1Withdrawn
- Sponsor
- University of Washington
- Start
- Dec 2023
- Primary completion
- Jan 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in head and neck cancer (HNC), sponsored by University of Washington. Primary endpoint: Intraoperative blood loss. Planned start Dec 2023; status: withdrawn.
02
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT05490381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05490381.